trio.smart PacificDx

trio-smart™ breath test for hydrogen, methane, and hydrogen sulfide

The trio.smart™ test optimizes the established breath testing methods for characterizing fermentation patterns in the gastrointestinal tract for the assessment of small intestinal bacterial overgrowth (SIBO). The test was developed and optimized by ResearchDx scientists to assess the levels of H2, CH4, and H2S in a patient’s breath after ingestion of a carbohydrate (lactulose) on a SIBO meter.

The trio.smart™ test PacificDx

trio.smart provides the complete fermented gas profile of a patient’s microbiome and is the only breath test to measure hydrogen sulfide (H2S) which is correlated to diarrhea.

For information about ordering this test visit triosmarbreath.com

Methodology: The trio.smart TM assay assesses the level of H2, CH4 and H2S in a patient’s breath after ingestion of a carbohydrate (lactulose) on a SIBO meter.

Contact us today to learn more about our extensive array of clinical, esoteric and consulting laboratory services for biopharmaceutical and clinical diagnostics laboratories. Or visit our companion diagnostics company, ResearchDx, to learn how our IVD and biopharma development services can simplify delivery of your FDA-approved companion diagnostics on time.